Sign in

CIK 0001676725 · Large accelerated filer

IDEAYA Biosciences, Inc.

Sign in to watch
Ticker
IDYA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
474268251
Phone
650-443-6209
Business address
5000 SHORELINE CT, SUITE 300, SOUTH SAN FRANCISCO, CA, 94080
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$985,397
in 1 filing, $985K under 10b5-1 plans

Net −$985,397. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Hata Yujiro S −$985K President and CEO sold 4% of stake
Date Insider Transaction Shares Price Value Owned after
2019-07-26 Stone Paul A. SVP, General Counsel Option exercise · Stock Option (right to buy) −10,000 145,932
2019-07-10 Hager Jeffrey SVP, Chief Technology Officer Option exercise +7,145 $4.31 $31K 122,656
2019-07-10 Hager Jeffrey SVP, Chief Technology Officer Option exercise · Stock Option (right to buy) −7,145 33,275
2019-06-19 Hager Jeffrey SVP, Chief Technology Officer Option exercise +8,628 $4.31 $37K 115,511
2019-06-19 Hager Jeffrey SVP, Chief Technology Officer Option exercise · Stock Option (right to buy) −8,628 40,420
2019-05-28 Alexandria Venture Investments, LLC 10% owner Conversion +382,384 382,384
2019-05-28 Alexandria Venture Investments, LLC 10% owner Purchase +50,000 $10.00 $500K 432,384
2019-05-28 Alexandria Venture Investments, LLC 10% owner Conversion · Series A preferred stock −3,149,405 0
2019-05-28 Alexandria Venture Investments, LLC 10% owner Conversion · Series B preferred stock −772,499 0
2019-05-28 DIEKMAN JOHN D Director Conversion +1,721,898 2,026,098
2019-05-28 DIEKMAN JOHN D Director Conversion +578,447 2,604,545
2019-05-28 DIEKMAN JOHN D Director Conversion +71,745 84,420
2019-05-28 DIEKMAN JOHN D Director Conversion +24,101 108,521
2019-05-28 DIEKMAN JOHN D Director Purchase +240,000 $10.00 $2.4M 2,844,545
2019-05-28 DIEKMAN JOHN D Director Purchase +10,000 $10.00 $100K 118,521
2019-05-28 DIEKMAN JOHN D Director Conversion · Series A Preferred Stock −1,721,898 0
2019-05-28 DIEKMAN JOHN D Director Conversion · Series B Preferred Stock −578,447 0
2019-05-28 DIEKMAN JOHN D Director Conversion · Series A Preferred Stock −71,745 0
2019-05-28 DIEKMAN JOHN D Director Conversion · Series B Preferred Stock −24,101 0
2019-05-28 Stone Paul A. SVP, General Counsel Conversion +1,721,898 2,026,098

Page 17 of 19 · 370 trades